EGFRvIII TandAbs are specific and highly potent drug candidates for the treatment of solid tumors. (4th November 2015) - Ellwanger, Kristina; Reusch, Uwe; Fucek, Ivica; Weichel, Michael; Gantke, Thorsten; Knackmuss, Stefan; Molkenthin, Vera; Marschner, Jens-Peter; Treder, Martin